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Abstract
Introduction: Mouse models of rheumatoid arthritis (RA) have proven critical for identifying genetic and cellular
mechanisms of the disease. Upon discovering mice in our breeding colony that had spontaneously developed
inflamed joints reminiscent of RA, we established the novel IIJ (inherited inflamed joints) strain. The purpose of this
study was to characterize the histopathological, clinical, genetic and immunological properties of the disease.
Methods: To begin the IIJ strain, an arthritic male mouse was crossed with SJL/J females. Inheritance of the
phenotype was then tracked by intercrossing, backcrossing and outcrossing to other inbred strains. The
histopathology of the joints and extraarticular organ systems was examined. Serum cytokines and
immunoglobulins (Igs) were measured by ELISA and cytometric bead array. Transfer experiments tested whether
disease could be mediated by serum alone. Finally, the cellular joint infiltrate and the composition of secondary
lymphoid organs were examined by immunohistochemistry and flow cytometry.
Results: After nine generations of intercrossing, the total incidence of arthritis was 33% (304 of 932 mice), with
females being affected more than males (38% vs. 28%; P < 0.001). Swelling, most notably in the large distal joints,
typically became evident at an early age (mean age of 52 days). In addition to the joint pathology, which included
bone and cartilage erosion, synovial hyperproliferation and a robust cellular infiltration of mostly Gr-1
+ neutrophils,
there was also evidence of systemic inflammation. IL-6 was elevated in the sera of recently arthritic mice, and
extraarticular inflammation was observed histologically in multiple organs. Total serum Ig and IgG1 levels were
significantly elevated in arthritic mice, and autoantibodies such as rheumatoid factor and Ig reactive to joint
components (collagen type II and joint homogenate) were also detected. Nevertheless, serum failed to transfer
disease. A high percentage of double-negative (CD4
-CD8
-) CD3
+ TCRa/b
+ T cells in the lymphoid organs of arthritic
IIJ mice suggested significant disruption in the T-cell compartment.
Conclusions: Overall, these data identify the IIJ strain as a new murine model of inflammatory, possibly
autoimmune, arthritis. The IIJ strain is similar, both histologically and serologically, to RA and other murine models
of autoimmune arthritis. It may prove particularly useful for understanding the female bias in autoimmune diseases.
Introduction
Rheumatoid arthritis (RA) is a systemic and chronic dis-
ease. The most characteristic symptoms are severe syno-
vial inflammation, cartilage and/or bone destruction and
bony nodule formation in the diarthrodial joints, but
extraarticular manifestations are also prevalent and
include pericarditis and vasculitis as well as pulmonary
complications such as pleuritis and pulmonary fibrosis
[1-3]. The worldwide prevalence of RA among adults is
estimated to be between 0.3% and 2%, with more
women affected than men [4-6]. Although the preva-
lence of RA does increase with age, the majority of
adults with RA are diagnosed between the ages of 30
and 50 years. A juvenile form of disease, with onset
before 16 years of age, does exist, and while differences
in classification and diagnosis make estimates difficult,
the prevalence of RA among children likely ranges
between 0.007% and 0.4% worldwide [7]. RA is a debili-
tating disease associated with increased mortality and a
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major cause of inability to work, with a little over one-
third of RA patients reporting an inability to work
within five years of diagnosis [9].
Unlike many other forms of arthritis, RA is autoim-
mune in nature. Autoantibodies are found in the vast
majority of patients. While B-cell autoantigens include
collagen type II, citrullinated proteins and glucose-6-
phosphate isomerase, the classic example is rheumatoid
factor (RF), an autoantibodys p e c i f i cf o rt h eF cp o r t i o n
of immunoglobulin G (IgG) [10]. RF is found in 70% to
80% of adult RA patients and has been used as a diag-
nostic indicator for the past five decades [11]. While B
cells have been successful targets for therapy in at least
a subset of patients [10,12,13], the focus has shifted
more toward T cells as the primary lymphocyte driving
disease [11,14-17]. Drugs that limit T-cell activation
help to ameliorate disease, and many of the genes asso-
ciated with an increased susceptibility to RA are
involved in T-cell function [11,18]. Though RA was
once described as “Th1-driven,” evidence is mounting
that Th17 cells are the primary T-helper cell subset pro-
moting disease [16,17,19].
While lymphocytes account for the autoreactivity in
RA, the inflammation itself results from a plethora of
cytokines that recruit peripheral immune cells, promote
synovial proliferation and induce osteoclast maturation
to increase bone resorption [11]. Many proinflammatory
cytokines, such as TNF-a and IL-6, have been the tar-
gets of therapeutic biologic drugs that successfully limit
inflammation [20]. Secreted primarily by activated
macrophages, TNF-a is believed to have a particularly
central role, as it induces the release of many other
cytokines and chemokines and activates many of the cell
types present in the inflamed synovium, including poly-
morphonuclear cells, endothelial cells, chondrocytes and
osteoclasts [21]. IL-6 is similarly known for its pleiotro-
pic functions [22]. It is the primary cytokine responsible
for the acute phase response observed in RA, contribut-
ing to systemic inflammation [21], and strongly influ-
ences lymphocyte maturation, promoting both plasma
cell and Th17 differentiation [23,24].
Mouse models of RA have been critical for under-
standing the underlying genetic and cellular mechanisms
of pathogenesis [25-27]. Both induced and spontaneous
models have been developed. In the most common
experimentally induced models, injection of adjuvant
and various joint matrix components, such as collagen
type II or proteoglycan aggrecan, causes autoimmune
arthritis in susceptible inbred mouse strains [28,29].
Spontaneous models can be subdivided by their mode of
origination: (1) development of autoimmune-prone
strains by selective mixing of previously existing inbred
strains (for example, the MRL/lpr strain [30,31]), (2)
targeted gene manipulation (for example, T-cell receptor
(TCR)-transgenic K/BxN model [32], TNF-a overex-
pression models [33], IL-1Ra-knockout [34] and
gp130
Y759F-induced mutant [35]) and (3) identification
of spontaneous mutants from breeding colonies (for
example, SKG mice with a point mutation in Zap-70
[36]). While these models replicate many aspects of
human RA, none of them mimic the disease completely.
In fact, it is unlikely that RA itself is a single disease,
but instead may be subdivided into various subsets (for
example, RF-seropositive and RF-seronegative) with dis-
tinct etiologies. Therefore, each mouse model is poten-
tially important not only for reinforcing the existence of
common or even universal mechanisms of disease but
also for revealing unique aspects not yet reflected in the
other models.
I nt h i sr e p o r t ,w ed e s c r i b ean e wm o u s el i n et h a t
spontaneously develops chronic inflammatory arthritis
most evident in the large distal joints. Called the IIJ
(inherited inflamed joints) strain, it was derived from
arthritic (AR) animals discovered in a breeding colony
at Northwestern University. One male AR mouse of pre-
dominantly SJL/J background was used to begin the line,
and, after 13 generations of inbreeding, the phenotype
remains stable. RA incidence in the entire colony is
approximately 33%, with females developing arthritis
more often than males. Joint histology confirmed carti-
lage and bone erosion, synovial proliferation and robust
leukocyte infiltration. In addition to the inheritance pat-
tern and histopathology, we describe the clinical and
immunological properties of disease.
Materials and methods
Mice
The IIJ strain was established from AR mice that
appeared in the 5B6 transgenic mouse-breeding colony
at Northwestern University. 5B6 mice were initially
developed at Harvard University [37]. While generated
on the FVB background, they were backcrossed for five
generations to SJL/J before being shipped to Northwes-
tern University, where they were then crossed with
Thy1.1 congenic SJL/J mice (backcrossed more than 12
generations to SJL/J). A subset of mice with inflamed
joints was discovered after several months. One AR
male mouse that was negative for the 5B6 TCR trans-
gene was crossed with SJL/J female mice to generate the
F1 generation of the IIJ line. Since then, the line has
been maintained with sibling-sibling mating. SJL/J mice
(six to nine weeks old) were purchased from Harlan
Laboratories (Indianapolis, IN, USA) or Taconic Farms
(Hudson, NY, USA) and used either directly in experi-
ments or as breeders. For inbred strain crosses, five- to
six-week-old female BALB/c, C3H, DBA1 and FVB mice
were purchased from Harlan Laboratories.
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facility at Northwestern University or in a HEPA-filtered
SuperMouse 750 ventilated rack and caging system (Lab
Products, Inc., Seaford, DE, USA) at Westmont College.
Antibiotic-treated mice were fed a modified Laboratory
Rodent Diet 5001 supplemented with 0.06% amoxicillin,
0.0138% metronidazole, 0.0037% bismuth and 0.0004%
omeprazole (Newco Distributors, Rancho Cucamonga,
CA, USA) for eight weeks. All protocols performed were
approved by the Institutional Animal Care and Use
Committee of Northwestern University and the Institu-
tional Review Board of Westmont College.
Evaluation of clinical disease
Clinical disease was evaluated using a subjective scoring
method similar to previous published methods [34,38]
with minor modifications. On a weekly basis, each paw
was assigned a score from 0 to 4 (0 = no disease; 1 =
minor, localized swelling; 2 = moderate swelling invol-
ving majority of paw; 3 = major swelling with paws two
to three times normal size; and 4 = deformity in large
or small joints of paw). Scores from one reading were
added together for the cumulative clinical score. Mice
were considered AR when they maintained a score ≥ 2
for one paw for two consecutive readings. Disease onset
was considered to be the first day that swelling was evi-
dent (score ≥ 1). For a subset of animals, disease was
also tracked weekly by measuring ankle thickness with
calipers. For each mouse, values for all four paws were
added together to calculate the cumulative ankle thick-
ness. At the time of joint scoring, the presence of other
clinical symptoms such as evidence of colitis was also
noted.
Histopathology and immunocytochemistry
Joints were prepared for H & E staining according to
previously published work [39]. Briefly, mice were killed,
and their paws were removed, fixed in 10% formalin,
decalcified and submerged again in 10% formalin until
processed for paraffin embedding. Tissue processing,
cutting of paraffin sections and H & E staining were
performed at AML Laboratories, Inc. (Rosedale, MD,
USA). In addition, live mice (five AR and two NAR IIJ
mice) were sent to the Comparative Pathology Labora-
tory at the University of California, Davis. An animal
necropsy was performed, and numerous organs and tis-
sues were harvested for analysis. Sections were exam-
ined and scored for inflammation in a blinded fashion
by a trained veterinary histopathologist.
Frozen tissue sections were prepared and stained
according to previously published methods [40]. Serial
frozen sections were cut and stained using biotinylated
primary antibodies or isotype controls (eBioscience, San
Diego, CA, USA) and the Tyramide Signal Amplification
Kit (PerkinElmer, Waltham, MA, USA). They were ana-
lyzed using a Leica DM5000 B fluorescence microscope
(Leica Microsystems, Buffalo Grove, IL, USA and SPOT
Advanced Software (SPOT Imaging Solutions, Sterling
Heights, MI, USA).
Serum isolation
Mice were given a lethal dose of Euthanasia 5 solution
( H e n r yS c h e i n ,I n c . ,P o r tW a s h i n g t o n ,N Y ,U S A ) ,a n d
blood was collected via cardiac puncture. Blood was
allowed to clot for a minimum of seven minutes at
room temperature. It was spun for 10 minutes at 10,000
rpm in a tabletop microcentrifuge. The serum was
removed and immediately frozen at -80°C until used.
Cytokine assays
The mouse inflammation cytometric bead array (CBA)
assay was performed according to the manufacturer’s
instructions (BD Biosciences, San Jose, CA, USA).
Serum was diluted 1:4 with assay diluent. The samples
were analyzed immediately using a FACSAria III cell
sorter and FACSDiva software (BD Biosciences). The
standard curves were made and calculations were per-
formed using the BD Biosciences CBA software. Serum
IL-17A levels were measured by ELISA using the manu-
facturer’s protocol (eBioscience). Serum was diluted 1:5.
Cell isolation and flow cytometry
Cells from lymphoid organs (spleens and lymph nodes)
were isolated as previously described [41]. The leg-
draining lymph nodes used included the axillary, bra-
chial, inguinal and popliteal. The joints were removed
and placed into a Petri dish containing 3 mL of sterile
DMEM. After mincing the joints with a sterile razor
blade, 1 mg/mL type II collagenase (Worthington Bio-
chemical Corp., Lakewood, NJ, USA) and 100 μg/mL
DNAse (Sigma-Aldrich, St Louis, MO, USA) were
added. After incubating the samples for one hour at 37°
C, a rubber plunger was used to push the tissue through
a sterile metal mesh in a Petri dish to generate a single-
cell suspension. The mesh was washed twice with 5 mL
of Hanks’ buffered saline solution (HBSS). Samples were
centrifuged for five minutes at 500 × g at 4°C, resus-
pended in 5 mL of HBSS and strained through a 70-μm
cell strainer. Live cells were counted in a hemocyt-
ometer using trypan blue exclusion.
Staining for flow cytometry was performed in 96-well
U-bottomed plates. Cells (0.5 to 1 × 10
6 cells/well) were
resuspended in 2% FCS in PBS, and a 1:100 dilution of
anti-mouse CD16/32 (eBioscience) was added. Cells
were incubated on ice for 15 minutes before antibody
mixtures were added for staining. All antibodies were
purchased from eBioscience (anti-mouse CD3ε-PE-Cy7,
CD3ε-APC, CD4-FITC, CD8-APC, CD11b-PE, CD45-
Adipue et al. Arthritis Research & Therapy 2011, 13:R114
http://arthritis-research.com/content/13/4/R114
Page 3 of 18FITC, B220-APC, Gr-1-Pacific Blue, TCRb-PE, Vb6-
FITC and Foxp3-APC), and their concentrations were
individually optimized in comparison to an isotype con-
trol. The anti-mouse DX5-PE antibody was purchased
from BD Biosciences. Cells were then incubated for 30
minutes on ice and washed three times with PBS. Cells
were resuspended in PBS and analyzed immediately or
fixed in 1% paraformaldehyde, stored overnight at 4°C
and analyzed the next day. Intracellular Foxp3 staining
was done using the Foxp3 Staining Buffer Set
(eBioscience) according to the manufacturer’si n s t r u c -
tions. Data were collected on a FACSAria flow cyt-
ometer and analyzed using FACSDiva software (BD
Biosciences) or FlowJo software (TreeStar, Inc., Ashland,
OR, USA).
Serum immunoglobulin ELISA
Total serum Ig, IgG1 and IgG2a levels were determined
by performing a sandwich ELISA based on the manufac-
turer’s published protocols (eBioscience). Plates were
coated with 2 μg/mL of polyclonal goat anti-mouse Ig
(553998; BD Biosciences) diluted in PBS. Serum was
diluted in 5% FCS/PBS at 1:200,000 for total Ig, 1:50,000
for IgG1 and 1:40,000 for IgG2b. The standards were
serial dilutions of mouse reference serum (Bethyl
Laboratories, Montgomery, TX, USA). Antibodies were
detected using 0.5 μg/mL biotinylated detection antibo-
dies (total Ig, 553999; IgG1, 553441; and IgG2a, 553388;
BD Biosciences), a 1:1,000 dilution of avidin-horseradish
peroxidase (eBioscience) and Super AquaBlue ELISA
Substrate (eBioscience). Concentrations were determined
using the standard curve and dilution factor. Duplicates
were averaged.
Total RF (that is, autoantibodies to IgG, IgM or IgA
isotypes specific for the Fc portion of IgG) was mea-
sured using a commercial kit following the manufac-
turer’s instructions (Alpha Diagnostic International Inc.,
San Antonio, TX, USA). Serum was diluted 1:250. Each
sample was run in duplicate and averaged. To normalize
between runs, the results are reported as percentages of
the manufacturer-provided positive controls [(Average
Abssample/Average Abs+control) × 100].
Other antigen-specific total Ig ELISAs were per-
formed by first coating high-binding 96-well plates
with either 20 μg/mL collagen type II (Sigma) or 15 to
20 μg/mL joint homogenate (kindly provided by Dr
Alison Finnegan). After the wells were washed, serum
was diluted 1:5 in PBS and added to wells in duplicate.
Reactivity was detected using the biotinylated anti-
mouse Ig, avidin-horseradish peroxidase and Super
AquaBlue ELISA Substrate mentioned above. Dupli-
cates were averaged, and the results are reported as
relative absorbance.
Serum transfers
Serum was pooled and pushed through a 0.2-μm syringe
filter to remove any contaminating cells. For each SJL/J
recipient, 300 μL of serum were injected intraperitone-
ally. Mice were tracked for disease for a minimum of
seven weeks. Mice were scored every two days for the
first four weeks and then scored twice weekly thereafter.
Statistics
Comparisons of disease incidence between groups were
analyzed using Fisher’s exact test. Means in the Ig ELI-
SAs, cytokine assays and T-cell subset analyses were
compared using an unpaired t-test. The mean percen-
tages of various cell types in joint or lymphoid organ
samples were compared by two-way analysis of variance.
Results
Occurrence of arthritis in a mouse-breeding colony and
the establishment of the IIJ strain
5 B 6m i c et r a n s g e n i cf o raT C Rs p e c i f i cf o ram y e l i n
peptide (proteolipid proteins 139 to 151) were brought
to Northwestern University and crossed with Thy1.1.
SJL/J congenics. After several generations, it was
observed that a small portion of the mice used as bree-
ders had noticeable swelling in their large distal joints,
a hallmark of disease in murine models of arthritis.
The inflammation was observed in both the forelimbs
(Figures 1A and 1B) and the hindlimbs (Figures 1C
and 1D). This phenotype had not been reported in the
5B6 breeding colony at Harvard University, the institu-
tion at which the transgenic mice were generated, or
in any report describing the use of Thy1.1.SJL con-
genics. Nevertheless, the arthritis phenotype appeared
to be heritable, as a portion of the progeny from the
breeders also developed inflamed joints. Arthritis
occurred independently of the expression of the trans-
genic 5B6 TCR, since the peripheral blood T cells in
s o m eo ft h eA Rm i c el a c k e dh i g he x p r e s s i o no fV b6, a
variable region used in the transgenic TCR (data not
shown). An AR male mouse that lacked expression of
the transgenic TCR but expressed Thy1.1 was crossed
with SJL female mice to establish a new line, the IIJ
strain. The strain has been maintained by brother-sis-
ter mating, and all mice used in this study were
derived from this cross. IIJ mice from the F10 and F11
generations were also screened for Vb6 expression in
their peripheral blood T cells and similarly lacked the
high expression characteristic of 5B6 mice (data not
shown). Furthermore, mice from the IIJ line never
showed signs of experimental autoimmune encephalo-
myelitis (EAE), the disease that spontaneously occurs
in the 5B6 strain [37], making presence of the TCR
transgenes highly unlikely.
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histopathology consistent with inflammatory arthritis
(Figures 1E, 1F, 1G, 1H, 1I, 1J). Both cartilage and bone
erosion was observed, along with notable inflammatory
infiltration, synovial proliferation and pannus formation.
A veterinary histopathologist examined the sections
from five AR IIJ mice (ranging from 98 to 277 days old)
and two NAR littermates in a blinded fashion. While no
inflammation was reported in the NAR mice, it was evi-
dent in multiple joints of the AR mice, including all the
joints in the paws (phalangeal, metacarpal/tarsal and
carpal/tarsal), the stifle (or “knee”) joint and, occasion-
ally, the vertebral joints. The cellular infiltrate was lar-
gely described as neutrophilic and histocytic and was
severe enough to cause abscess formation in some of
the most severely AR mice. Myeloid hyperplasia was
also observed in the bone marrow.
Non-Mendelian inheritance of the arthritis phenotype and
influence of genetic background
A complex pattern of inheritance of the arthritis pheno-
type was observed in the IIJ strain (Figure 2A). The
initial cross between an AR male mouse and SJL/J
female mice produced F1 progeny with a disease inci-
dence of 32% (12 of 37), suggesting a possibly dominant
phenotype. However, crosses involving two AR F1 mice
or an AR F1 male and a NAR F1 female produced pro-
geny with a similar incidence (just under 30%), a general
pattern that was maintained in later generations. Only
one litter was produced from a cross between two NAR
F1 mice, and none of the progeny developed arthritis
(zero of six). However, in later generations (F2 to F4),
NAR × NAR crosses consistently produced AR progeny
(incidence ranging from 17% to 89%, depending on
breeder).
Figure 1 Robust inflammation in the fore- and hindpaws of arthritic IIJ mice. (A) and (B) Forepaws and (C) and (D) hindpaws of (B) and
(D) arthritic (AR) and (A) and (C) nonarthritic (NAR) IIJ littermates. Mice were > 16 weeks old. (E) through (J) H & E-stained sectionsof formalin-
fixed and decalcified paws. (E) through (G) Hindpaws (total magnification, ×40). (E) NAR littermate. (F) 46-day-old AR mouse 7 days after onset.
(G) 141-day-old AR mouse 103 days after onset. (H) through (J) Forepaws (total magnification, ×100). (H) NAR littermate. (I) 58-day-old AR
mouse 26 days after onset. (J) 261-day-old AR mouse 233 days after onset. Histological studies are representative of samples taken from nine AR
and seven NAR littermates.
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but the incidence remained at 33% overall (304 of 932)
(Table 1). Furthermore, the incidence was close to one-
third, regardless of the phenotype of either parent,
although it was slightly higher when the dam was AR
(198 (35%) of 562) than when the dam was NAR (106
(29%) of 370), regardless of the sire’sp h e n o t y p e( P <
0.05). The phenotype did appear to be sex-influenced, as
female mice had a higher incidence than male mice
(38% vs. 28%; P < 0.001). This pattern was observed
regardless of the phenotype of the parents, although it
was statistically significant only in the AR × AR group
(P < 0.05). Taken together, these data indicate that the
arthritis phenotype is not inherited in a simple Mende-
lian fashion and that females are more susceptible to it
than males.
Multiple attempts were made to backcross AR IIJ
mice further to SJL/J to determine whether the arthritis
incidence could be increased if the contaminating FVB
genes were removed (Figure 2B). Male and female AR
F1
F2
F3
F4
A.
7 5 14 11
32%
11 9 26 25
28% 27%
12 15 24 49 24
0%
266 9476 75 2 7 3
2 52 1
0 75 4 2 6
20% 50% 17% 29% 53%
SJL/J
Non-arthritic (NAR)
Arthritic (AR)
10 10 21 32 6 2 13 14 3 5 1 6 3 7 14
32% 23% 89% 30%
52 10 7
29%
5 2 15 17
23 2 88
12%
64 1 1 17
26%
18%
11% 11%
8%
3 21 16
217
1
8 31 31 2
F3
5
B.
13%
F5
93 2 4
67%
12 5
7%
F6
91 0 3 1 3
54%
194
13%
F10
56 16 12
28%
21 10 10
1
Figure 2 Complex pattern of inheritance of arthritis phenotype in the IIJ strain. Pedigrees representing the inheritance of the arthritis
phenotype in multiple generations of IIJ mice after intercrossing or backcrossing. The arthritis incidence in a particular phenotypic cross in each
generation is shown as a percentage above the progeny. The number inside each symbol represents the number of progeny of that sex and
phenotype. For conciseness, the results of a particular phenotypic cross were combined within a line for each generation. (A) Pedigree of the
first four generations of the IIJ strain. One of the nontransgenic arthritic males from the 5B6 colony was crossed with SJL/J females to establish
the IIJ strain. The strain was then maintained by sibling-sibling mating. (B) AR IIJ mice from various generations (noted as F3, F5 and F6 next to
cross) were backcrossed to SJL/J, and the progeny were tracked for disease.
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crossed with SJL/J mice, and the progeny were tracked
for disease. After consistently backcrossing or backcross-
ing followed by intercrossing, the incidence only
decreased. It also decreased regardless of whether female
or male AR IIJ mice were used for backcrossing. There-
fore, FVB alleles likely contributed to the AR phenotype.
To further test the influence of genetic background on
arthritis incidence, AR IIJ mice were also crossed with
FVB and three other pro-AR inbred strains: BALB/c and
CH3, two strains susceptible to proteoglycan-induced
arthritis [29], and DBA1, a strain susceptible to col-
lagen-induced arthritis [28]. AR male IIJ mice were
crossed with two inbred strain females (two breeders
per strain), and their progeny were tracked for disease.
Arthritis incidence was minimal in all four strains, with
only one IIJ × FVB progeny and one IIJ × C3H progeny
developing disease (Table 2). When F1 siblings were
intercrossed to generate a second generation, arthritis
incidence again was low, never exceeding 8%. Therefore,
since backcrossing to SJL or to other inbred strains only
decreased arthritis incidence, the line was maintained by
sibling-sibling intercrossing.
Progression of clinical disease varied between arthritic IIJ
mice
AR mice in the first four generations of the IIJ line were
tracked for progression of clinical disease for a mini-
mum of four months. Mice were scored weekly for dis-
ease on each paw, and the scores for each paw were
added together to calculate the cumulative clinical
score. A subset was also measured with calipers for
ankle thickness (data not shown), which showed that
AR mice had an increased cumulative ankle thickness
compared to NAR mice and corroborated the subjective
scoring method. On average, mice developed arthritis at
approximately 7.5 weeks of age (51.8 postnatal days
(pnd)), though onset ranged from 21 pnd (that is, arthri-
tis at weaning) to > 150 pnd (Figure 3A). The age at
onset was not significantly different between male and
female mice. Once becoming classified as AR, most
mice maintained that status throughout their lifetime.
Clinical disease resolved in only 6% of the animals (Fig-
ure 3E). Clinical progression, total number of paws
affected and peak severity did vary widely between mice
(Figures 3B, 3C, 3D). While almost one-half of the AR
mice developed inflammation on all four paws, one-
fourth of them developed inflammation in only one or
two paws, showing an occasionally asymmetric progres-
sion. Similarly, the peak severity of disease ranged from
severe (44% with peak cumulative joint scores between
11 and 16) to moderate (35% with peak scores between
6 and 10), to mild (21% with peak scores between 2 and
5). Examples of disease progression for individual mice
are shown in Figure 3B. Overall, clinical disease showed
significant variability between mice.
Typical signatures of local and systemic inflammation in
arthritic IIJ mice
While H & E staining clearly showed robust cellular
infiltration into the joints of AR IIJ mice, flow cytometry
and immunohistochemistry were used to identify the
types of immune cells present. Cells were isolated from
the joints of AR and NAR littermates using collagenase
digestion. Not surprisingly, the average number of cells
isolated from joints of AR IIJ mice was over 10 times
greater than the average number isolated from NAR lit-
termates (14 million vs. 1.3 million) (Figure 4A). Flow
cytometry revealed that the vast majority of immune
cells (CD45
+) were neutrophils (CD11b
+Gr-1
+), though
Tc e l l s( C D 3
+), B cells (B220
+) and macrophages
(CD11b
+Gr-1
-) were also present at low levels (Figure
4B). Immunohistochemistry confirmed that Gr-1
+
Table 1 Combined incidence of arthritis in first nine
generations of IIJ strain
a
Progeny
Phenotype of
parents
b
Total Female Male
Male × Female, n (%)
AR × AR 159 of 463
(34%)
84 of 207
(41%)
75 of 256
(29%)
AR × NAR 77 of 273
(28%)
41 of 120
(34%)
36 of 153
(24%)
NAR × AR 39 of 99 (39%) 22 of 53 (42%) 17 of 46 (37%)
NAR × NAR 29 of 97 (30%) 15 of 44 (34%) 14 of 53 (26%)
Overall, n (%) 304 of 932
(33%)
162 of 424
(38%)
142 of 508
(28%)
aProgeny were considered arthritic when they maintained a score of 2 (see
Materials and methods for details) on the same paw for two consecutive
readings. Results were combined based on phenotype of parents regardless
of generation.
bArthritic (AR) or nonarthritic (NAR); all were intercrosses
between littermates.
Table 2 Low incidence of disease when arthritic IIJ mice
were crossed with four other inbred strains
a
Cross
b Cage F1 F2
AR × BALB/c 1 0 of 13 2 of 25
2 0 of 18 0 of 19
AR × FVB 1 0 of 13 0 of 23
2 1 of 22 2 of 38
AR × DBA1 1 0 of 20 0 of 21
2 0 of 13 1 of 20
AR × C3H 1 1 of 16 0 of 24
2 0 of 15 0 of 25
aMice were followed for an average of 120 postnatal days and a minimum of
90 postnatal days, except in rare cases (< 2.5%) when males were killed earlier
because of fighting with cagemates.
bArthritic (AR) males from the IIJ strain
were crossed with females from inbred strains. All arthritic F1 mice were used
to generate the F2 generation.
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Page 7 of 18neutrophils were the primary cell type in the inflamed
joints, where they could be seen concentrating in
abscesses (Figure 4C). Some CD4
+ T cells could also be
seen in the inflamed joints, and while F4/80
+ myeloid
cells could be seen throughoutt h eh e a l t h yj o i n t s ,t h e s e
were presumably tissue-resident cells, and their numbers
increased and changed in distribution in the inflamed
joints.
To determine whether typical proinflammatory cyto-
kines were elevated in the AR IIJ mice, serum was col-
lected from AR mice at early and late stages of disease
and from NAR littermates, and a CBA assay was per-
formed to determine the level of six inflammatory cyto-
kines. Though IL-12p70, monocyte chemotactic protein
1, IFN-g and IL-10 were undetectable in all animals, IL-
6 was elevated in all of the AR mice at early stages of
disease (Figure 5A). TNF-a was only detected in four of
eight AR, but none of the mice had levels twice the
minimal level of detection of the assay (Figure 5B).
Serum IL-17A was measured by ELISA but was also
undetectable. Taken together, the significant infiltration
of immune cells into the joints and the presence of IL-6
i nt h es e r ao fA Rm i c ea r ei n d i c a t i v eo ft h er o b u s t
inflammation occurring in the AR mice, both locally in
the joint and systemically.
Though serum Ig and autoantibodies were elevated in
arthritic IIJ mice, serum failed to transfer disease
To determine whether any lymphocyte population was
expanded and possibly activated in the AR mice, cells
were isolated from the spleens and leg-draining lymph
nodes of IIJ littermates and stained for flow cytometric
analysis. Though the cellular makeup of the spleens did
not differ significantly between the AR and NAR IIJ
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A
4 paws
49%
3 paws
27%
2 paws
11%
1 paw
13%
Severe 
44%
Moderate
35%
Mild
21%
Re-
solving
6%
Chronic
94%
C D E
Average Onset
Total: 51.8 (n=118)
Female: 50.1 (n=68)
Male: 54.0 (n=50) 
B
Figure 3 Onset, progression, severity and persistence of clinical disease.A Rm i c e( N = 63; females = 34, males = 29) in the first four
generations were followed for a minimum of 126 postnatal days (pnd) (average = 157 pnd) with a minimum of eight weekly readings (average
= 12). The mice were scored on a weekly basis for the severity of clinical disease (see Materials and methods for details). (A) Histogram showing
pnd at onset of clinical disease. While mice were classified as AR when they maintained a score of 2 for two consecutive readings, onset was
designated as the first score ≥ 1. (B) Progression of cumulative clinical scores over time for selected AR mice. (C) The maximum numbers of
paws affected are shown. Affected paws had a score ≥ 1. (D) The maximum severity of disease based on peak of cumulative clinical score is
shown (mild = 2 to 5, moderate = 6 to 10 and severe = 11 to 16). (E) Chronic vs. resolving disease is shown. An AR mouse was classified as
having chronic disease when it had a cumulative clinical score ≥ 2 for every weekly reading after onset. Resolving disease was deemed to have
occurred when the cumulative joint score dropped below 2 and disease never recurred.
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Page 8 of 18mice, a significant difference was found in the lymph
nodes (P <0 . 0 5 )( F i g u r e6 ) .T h er e l a t i v ep e r c e n t a g eo f
CD3
+ T cells was lower and the relative percentage of
B220
+ B cells was higher in the AR mice compared to
NAR littermates.
Given this relative expansion in the B-cell population,
serum Ig levels were measured by ELISA (Figure 7).
Though the levels were variable, AR mice had, on aver-
age, higher levels of total Ig in their serum compared to
NAR littermates (Figure 7A). Upon examination of indi-
vidual isotypes, AR mice also had higher levels of IgG1
(Figure 7B) but similar levels of IgG2a (Figure 7C). To
investigate antigen-specific reactivity, total Ig RF and Ig
specific for collagen type II or joint homogenate were
examined. Compared to NAR littermates, AR IIJ mice
had, on average, higher serum levels of anti-collagen
type II and anti-joint homogenate antibody (Figures 7D
and 7E, respectively), though, again, significant variabil-
i t yw a so b s e r v e d .A Ra n dN A Rm i c eh a de q u i v a l e n t
mean levels of RF, but levels in both groups were signif-
icantly higher than in age-matched SJL/J controls (Fig-
ure 7F). Ultimately, 7 (63.7%) of 11 NAR IIJ mice and 8
(72.7%) of 11 AR IIJ mice had RF levels at least twice
the mean SJL/J RF level. Nevertheless, despite these dif-
ferences in averages, there were AR mice without higher
levels of total Ig, IgG1, RF or anti-collagen or anti-joint
homogenate antibodies, calling into question a patho-
genic role for antibodies in disease.
Therefore, sera from AR mice were adoptively trans-
ferred into SJL/J mice to determine whether serum
alone could transfer disease. Three hundred microliters
of filtered and pooled sera from either AR or NAR mice
C
AB
rIgG2a 
Isotype Anti-CD4 Anti-Gr-1 Anti-F4/80
rIgG2b 
Isotype
NAR
AR
AR
Figure 4 Flow cytometric and immunohistochemical analyses of cell types present in the inflamed joints of IIJ mice. (A) and (B) Cells were
isolated from the inflamed paws of AR mice and the corresponding noninflamed paws of NAR littermates. Cells were stained with antibody
mixtures and analyzed by five-color flow cytometry (n = 5 to 6 mice/group). (A) Average number of cells isolated. Error bars represent standard
error of the mean (SEM). (B) Average number of cells of specific immune lineages (CD3
+ = T cell, B220
+ = B cell, CD11b
+Gr-1
+ = neutrophil, CD11b
+Gr-1
- = macrophage). Error bars represent SEM. After gating on live, CD45
+ cells, the percentages of each cell type were determined. This value
was then multiplied by the total cells isolated from that animal to determine the final number of each cell type. (C) Immunohistochemical staining
of serial sections of hindpaws from AR and NAR mice. Frozen sections were stained with biotinylated primary or isotype control antibody and
detected using the Tyramide Signal Amplification Kit from PerkinElmer (staining shown in pink). The rat immunoglobulin 2a (Ig2a) isotype is the
control for the anti-CD4 stain. The rat Ig2b isotype is the control for the anti-Gr-1 and anti-F4/80 stains. The mounting media contained 4’,6-
diamidino-2-phenylindole (staining shown in blue) for nuclear stain. AR mice were between 80 and 95 days old.
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Page 9 of 18were injected intraperitoneally into SJL/J mice, which
were then tracked for disease. The mice were followed
for over two months, but no mice (zero of six with
NAR serum injected into SJL/J mice and zero of seven
with AR serum into SJL/J mice) developed arthritis.
A large proportion of CD4
-CD8
- (double-negative) T cells
in the lymph nodes of arthritic IIJ mice
Given the relative decrease in the proportion of T cells
in the lymph nodes of the AR mice, T cells and subpo-
pulations were examined in more detail (Figure 8). Cells
from the leg-draining lymph nodes of young (6- to 8-
week-old) and old (16- to 17-week-old) IIJ mice were
isolated, counted, stained with antibody mixtures and
analyzed by flow cytometry. Though the total number of
cells isolated was elevated in AR mice compared to their
NAR IIJ mice littermates (Figure 8C), the total number
of a/b T cells was unchanged (Figure 8D), suggesting
that the relative decrease in the percentage of CD3
+
cells (Figure 6) was more likely due to an expansion of
B220
+ B cells than to a contraction of CD3
+ T cells spe-
cifically. g/δ T cells were rare and were not different
between groups (data not shown).
Nevertheless, a/b T cell subpopulations were signifi-
cantly altered. The majority of the T cells in the lymph
nodes of AR mice were, surprisingly, CD4
-CD8
-, or dou-
ble-negative (DN) (Figure 8A), a population extremely
rare in normal mice. While the number of DN T cells
AB
Figure 5 Cytokine levels in serum of nonarthritic IIJ mice and arthritic IIJ mice at early and late stages of disease. Serum was isolated
from AR and NAR littermates, and the levels of six cytokines were measured by cytometric bead array. Only (A) IL-6 and (B) TNF-a were
detected. IL-12p70, IL-10, monocyte chemotactic protein 1 and IFNg were measured but not detected. Early AR mice were < 2.5 months old and
had had arthritis for < 5 weeks. Late AR mice were > 4 months old and had had arthritis for > 11 weeks. Dashed horizontal line represents the
minimum level of detection. Solid horizontal line represents the average per group. **P < 0.01. Filled circles, squares, and triangles represent data
points from NAR. Early AR, and Late AR mice, respectively. Serum IL-17A was measured by standard ELISA but was not detected (data not
shown).
AB
Figure 6 Cellular composition of lymphoid organs in IIJ mice. (A) and (B) Average number of cells of specific immune lineages in (A)
lymph nodes and (B) spleens of AR or NAR IIJ mice based on flow cytometric analysis. Error bars represent SEM. Live cells were gated on and
the amount of each cell type (CD3
+ = T cell, B220
+ = B cell and CD11b
+ = myeloid/granulocyte) was determined as the percentage of CD45
+
cells. All AR mice were more than seven weeks old and had been arthritic for a minimum of four weeks. NAR mice were littermates or age-
matched within two weeks (n = 4 to 5 mice/group). Groups were compared by two-way analysis of variance, and cellular composition varied
significantly in the lymph nodes (P < 0.05) but not in the spleens.
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Page 10 of 18was expanded in young and old AR mice, the number of
CD4
+ T cells was decreased, showing a loss of this sub-
set specifically (Figure 8F). A similar, though less pro-
nounced trend was also observed in the spleen (data not
shown). To determine whether the decrease in CD4
+ T
cells resulted from a loss of T-regulatory cells (Tregs),
CD25
+Foxp3
+ cells were examined (Figure 8E). AR mice
in fact had more Tregs in their lymph nodes than their
NAR littermates, suggesting an expansion of this popu-
lation during chronic joint inflammation. This increase
was seen in both 6- to 8-week-old and 16- to 17-week-
old mice, and similar results were found when identify-
ing Tregs on the basis of CD25 and GITR expression
(data not shown). While the functionality of the Tregs is
not known, the joint inflammation does not appear to
be a result of a decline in this regulatory population.
The DN T cells were examined further for signs of
activation and for additional lineage markers that might
suggest their origins. To determine their activation and/
or memory phenotype, CD69 upregulation (a reflection
of recent activation) and CD45RB downregulation (a
reflection of previous activation) were compared
between T-cell subsets in AR mice (Figure 8B). While
25% to 45% of CD4
+ and CD8
+ T cells showed robust
signs of activation, activation was low in the DN subset,
calling into question whether the DN cells have a direct
pathogenic role. Finally, since natural killer (NK) T cells
lack CD4 and CD8 expression but are positive for the
a/b TCR, the DN cells were examined for NK cell mar-
kers. More than 85% of the DN T cells lacked the pan-
NK cell marker DX5 (Figure 8G), and therefore their
origin is still under investigation.
Typhlocolitis and other extraarticular manifestations of
inflammation in IIJ mice
In the F5 generation, a subset of IIJ mice started devel-
oping diarrhea, which is possibly indicative of inflamma-
tory bowel disease (IBD). Joint inflammation often
accompanies IBD in humans, and therefore a link
between the two diseases has been suggested [42,43].
Though some mice seemed to have diarrhea chronically,
most only showed signs transiently. H & E staining of
the GI tracts revealed evidence of typhlocolitis (inflam-
mation of the cecum and colon) in all the AR mice
examined, regardless of whether they showed signs of
diarrhea at the time of organ harvest (Table 3 and Fig-
ures 9A, 9B, 9C, 9D). Gut pathology was characterized
by significant lymphocytic, plasmacytic and neutrophilic
infiltration into the submucosa, as well as marked
mucosal hyperplasia and crypt abscess formation (Fig-
ures 9A, 9B, 9C, 9D). Though the two NAR IIJ mice
examined showed no histological signs of typhlocolitis,
AB C
DE F
Figure 7 Serum immunoglobulin levels in IIJ mice and age-matched SJL/J controls. Serum was collected and Ig measured by ELISA. (A)
through (C) Average levels of (A) total Ig, (B) IgG1, (C) IgG2b, (D) anti-collagen type II Ig and (E) anti-joint homogenate Ig. AR and NAR IIJ mice
were littermates and were between 87 and 207 days old. No correlations between antibody level and age, sex, disease severity or days since
disease onset were found (data not shown). (F) Amount of total Ig rheumatoid factor (RF) in NAR and AR littermates and age-matched SJL/J
controls. All mice were 55 to 189 days old, and AR mice had had clinical disease for a minimum of four weeks. RF level did not correlate with
total Ig or age (data not shown). Groups were compared by performing a t-test. Filled circles, squares, and triangles represent data points from
NAR. Early AR, and Late AR mice, respectively.
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Figure 8 Presence of double-negative (DN) T cells in lymph nodes of arthritic IIJ mice. Cells were isolated from the leg-draining lymph
nodes of AR and NAR littermates. They were stained and analyzed by flow cytometry. (A) Representative CD4 vs. CD8 density plots. Live CD3
+
TCRa/b
+ cells were gated on, and the percentage in each quadrant is shown. (B) Percentage of cells of each T-cell subset with activation/
memory phenotype in arthritic mice (> 7 weeks old and arthritic for a minimum of 4 weeks) (n = 4 to 6 mice). (C) through (F) Comparison of
absolute numbers of (C) cells isolated, (D) CD3
+ TCRab
+ T cells, (E) CD4
+ CD25
+ Foxp3
+ T-regulatory cells and (F) single positive (CD4
+ and CD8
+) and DN (CD4
-CD8
-) T cells. For cell subsets, absolute numbers were back-calculated from percentages and number of total cells isolated. (G)
Number of DN T cells that expressed the natural killer T-cell marker DX5 (n = 3 for each group in (C) through (G)). Data are means ± SEM.
Groups were compared by performing a t-test (*P < 0.05, ***P < 0.001). Similar results were found in the spleens (data not shown).
Table 3 Extraarticular inflammation in arthritic IIJ mice
Inflammation score
a
IIJ mouse Arthritis Diarrhea
b Age, days Colon/cecum Lung Liver Kidney Heart
1 Y Y 192 +++ - - - -
2 Y Y 98 +++ ++ - - -
3 Y N 147 + + + + -
4 Y N 219 ++ + + ++ +
5 Y Y 277 +++ - ++ + -
6NN9 8 - - - - -
7 N N 219 - - - - -
a(-) no inflammation, (+) mild to minimal inflammation, (++) moderate inflammation, (+++) severe inflammation;
bat time of organ harvest.
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through five generations of IIJ mice revealed that both
AR and NAR IIJ mice developed diarrhea (Table 4). Of
273 mice tracked for IBD, 40% showed signs of diarrhea
at least once at their weekly scoring for joint inflamma-
tion. Of the mice that had diarrhea, 66 (60%) of 110
also had arthritis. While this subset of IIJ mice showed
the significant female bias in arthritis incidence (P <
0.05), no sex bias was observed in the incidence of diar-
rhea. SJL/J sentinel mice that received bedding from all
the IIJ cages on the same rack never developed diarrhea
or arthritis, indicating that IBD was specific to the IIJ
strain.
To screen for possible GI pathogens, eight IIJ mice (five
AR and three NAR) and four sentinel SJL/J mice from
the colony were sent to the Comparative Pathology
Laboratory at the University of California, Davis. All the
IIJ mice, regardless of arthritis status, tested positive for a
Helicobacter sp: six had H. rodentium a n dt w oh a da
Helicobacter sp. of undetermined type. They did not test
positive for other GI tract pathogens, including pinworm.
None of the SJL/J sentinels tested positive for Helicobac-
ter spp. Believed to be a part of the normal intestinal
flora, H. rodentium was originally identified in 1997,
when it was isolated from the intestines of asymptomatic
laboratory mice [44]. It was later found to cause mild to
moderate colitis in IL-10-deficient mice [45] and severe
IBD only when the mice were coinfected with other,
more pathogenic Helicobacter spp. [45-47]. Treating IIJ
mice with food tablets containing a four-antibiotic drug
cocktail (0.06% amoxicillin, 0.0138% metronidazole,
0.0037% bismuth and 0.0004% omeprazole) resolved
their diarrhea within three weeks (Figure 9E), and after
eight weeks of treatment, the IIJ mice tested negative for
all Helicobacter spp. (data not shown). While IIJ mice
with active diarrhea had an elevated colon:body weight
ratio, indicating inflammation, antibiotic treatment
caused the ratio to normalize and become similar to the
ratios of IIJ mice that had never had diarrhea (Figure 9F).
While this finding does not prove that Helicobacter spp.
infection specifically induced typhlocolitis in the IIJ mice,
the correlation suggests that it might.
To determine whether the IIJ mice had evidence of
inflammation in tissues other than the joints and the
AB
CD
E
F
Figure 9 Typhlocolitis in a subset of IIJ mice. H & E-stained tissue sections of paraffin-embedded (A) and (B) colon and (C) and (D) cecum
from IIJ mice (total magnification, ×100). (A) and (C) Noninflamed tissue from a NAR, 98-day-old IIJ mouse and (B) and (D) inflamed tissue from
its AR littermate. Images are representative of sections from seven mice (see Table 3 for details). (E) Effective treatment of diarrhea with
antibiotic-containing mouse chow. Mice were started on mouse chow and checked weekly for signs of diarrhea. (F) Colon:body weight ratios (g:
g) for three groups of IIJ mice: mice that had never had diarrhea, mice with active diarrhea and mice that used to have diarrhea but had been
successfully treated with antibiotics.
Table 4 Incidence of inflammatory bowel disease in IIJ
strain
a
Disease manifestation Total, n (%)
(n = 273)
Females, n (%)
(n = 131)
Males, n (%)
(n = 142)
Arthritis 112 (41%) 64 (49%) 48 (34%)
Diarrhea 110 (40%) 49 (37%) 61 (43%)
Arthritis and diarrhea 66 (24%) 35 (27%) 31 (22%)
aMice were considered to have inflammatory bowel disease if they ever
showed signs of diarrhea at time of weekly scoring for joint inflammation.
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Page 13 of 18colon, various organs were harvested, stained with H &
E and examined in a blinded fashion by a trained veter-
inary histopathologist. In addition to typhlocolitis, other
extraarticular inflammation was observed in all of the
AR mice, though the organs involved and the severity of
inflammation were inconsistent (Table 3). Inflammation
was noted in the lungs of three of five AR animals (two
with mild to minimal inflammation and one with focal
pleuritis). A similar number also showed inflammation
in the liver and/or kidneys. Inflammation severity ran-
ged from minimal to moderate, although one AR IIJ
mouse had pronounced moderate interstitial nephritis
and fibrosis in the kidneys. Finally, severe vasculitis was
seen in the vertebrae of the oldest IIJ arthritis mouse
(data not shown). The NAR IIJ mice showed no signs of
inflammation in any organ (Table 3). Therefore, simi-
larly to humans with RA, the AR IIJ mice had extraarti-
cular manifestations of disease, indicating pathology of a
systemic nature.
Discussion
In this report, we describe a new strain of mouse, which
we have named the IIJ strain, that spontaneously devel-
ops chronic inflammatory, and possibly autoimmune,
arthritis that shares many similarities with human RA
and other mouse models of arthritis. Though visible
swelling was most evident in the large distal joints of IIJ
mice, histological hallmarks of arthritis, including bone
and cartilage erosion, invasive synovial hyperprolifera-
tion and immune cell infiltration were observed in all
joints of the hindlimbs and forelimbs (Figure 1). Overall,
the histopathology was similar to that described in pre-
viously published mouse models of autoimmune arthritis
[32,34-36]. In addition, the predominantly neutrophilic
and lymphocytic infiltration into the inflamed IIJ joints
(Figure 4) parallels the high number of neutrophils and
T cells present in the inflamed synovial fluid of RA
patients [48,49]. Also similar to RA, inflammation was
not restricted solely to the joints of IIJ mice, but was
systemic in nature. Elevation of serum proinflammatory
cytokines (Figure 5) and histological signs of inflamma-
tion, ranging from mild to severe, were observed in var-
ious organs (Table 3). Extraarticular manifestations of
disease have also been noted in IL-1R antagonist-defi-
cient [50] and SKG mice [36]. Finally, the IIJ mice also
share serological similarities with RA and other mouse
models. Compared to NAR littermates, AR IIJ mice had
mildly elevated serum Ig, which is due, at least partially,
to elevated IgG1, a classic Th2-induced isotype (Figure
7). RA patients also have slightly increased serum Ig
levels [51], and researchers who have studied several
spontaneous mouse models of arthritis, including the K/
BxN [32], gp130
Y759F[35] and IL-1R antagonist defi-
ciency models [34], have reported increases in IgG1
specifically. Importantly, autoantibodies were also
detected in our study, as many IIJ mice were positive
for RF and antibodies specific to joint components (Fig-
ure 7).
The arthritis incidence in IIJ mice also displayed the
sex bias common to many complex autoimmune dis-
eases, such as RA, multiple sclerosis and systemic lupus
erythematosus (SLE) [52]. RA incidence was higher in
females than in males (38% vs. 28%; P < 0.001) (Table
1), though ultimately clinical severity and mean day of
onset did not differ significantly. The sex bias appeared
to be specific for the arthritis phenotype, since the inci-
dence of typhlocolitis was similar between male and
female IIJ mice (Table 4). As most models reach 100%
incidence in both sexes, no other spontaneous mouse
model of arthritis has found such a sex bias, although
researchers who have studied both the SKG [36] and
gp130
Y759F models [35] have noted more severe arthritis
in females. A female bias in incidence was observed in
collagen-induced arthritis in humanized HLA-DR4-
transgenic mice [53] and was attributed to both hyper-
active B cells and HLA-DR4-restricted antigen presenta-
tion in female mice and increased numbers of Tregs
and B-regulatory cells in male mice [54]. The reason for
the sex bias in arthritis incidence in IIJ mice remains
unknown.
It remains unclear whether arthritis in the IIJ mice is
truly autoimmune. The similarities to RA and other
mouse models of autoimmune arthritis outlined above
would strongly argue in favor of this scenario. The rela-
tive expansion of the B-cell population, elevated serum
Ig and presence of autoantibodies are also strongly sug-
gestive that this is true. Nevertheless, all AR IIJ mice did
not have levels of serum autoantibodies that exceeded
those of NAR littermates (Figure 7), and the increase
might simply be a side effect of chronic inflammation.
Some murine models of arthritis have shown elevated
levels of Ig and autoantibodies, but the arthritis was
lymphocyte-independent. For example, joint inflamma-
tion still occurs in the N-ethyl-N-nitrosourea-induced
mutants Ali5 and Ali18,e v e nw h e nc r o s s e dt oR a g 1
-/-
backgrounds [55,56]. Finally, transfer of sera from AR
IIJ mice failed to induce disease in SJL/J hosts, suggest-
ing that antibodies alone are not sufficient to cause dis-
ease. It is possible that not enough serum was
transferred and/or that it was not transferred by the
appropriate method (for example, intravenous rather
than intraperitoneal injection). Nevertheless, the same
transfer protocol successfully transfers disease in anti-
body-dependent arthritis models such as the K/BxN
model [57].
The appearance of a high percentage of DN T cells in
the peripheral lymphoid organs does indicate that the
T-cell compartment in the AR IIJ mice is significantly
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Page 14 of 18disrupted (Figure 8). DN T cells are characteristic of
S L Ei nh u m a n sa sw e l la si nm u r i n em o d e l so fS L E ,
such as the MRL/lpr mouse, a strain that also gets
arthritis [58,59]. Since the peripheral DN T cells in
MRL/lpr mice are B220
+ [59] and those in IIJ mice are
B220
- (data not shown), it is unlikely that these mouse
populations are identical. The origin of the DN T cells
in IIJ mice remains unclear. It does not appear to
caused by an expansion of NK T cells, as DN T cells
lack the pan-NK cell marker DX5 (Figure 8G), and their
high expression of CD3 and the TCR suggests that they
are mature. The fact that CD4
+ T cells decrease in num-
ber as DN T cells increase does suggest that the DN T
cells might be CD4
+ cells that have downregulated CD4.
While downregulation of TCR coreceptors by viruses
have been well documented [60], it has also been pro-
posed as a natural mechanism of peripheral tolerance
[61,62]. Autoreactive T-cell clones can downregulate
CD4 upon long-term stimulation in vitro [63], and self-
specific TCR-transgenic mice can downregulate corecep-
tors to control autoimmunity [64]. Nevertheless, the fact
that the IIJ DN T cells largely lack an activated and/or
memory phenotype (Figure 8B) argues against corecep-
tor downregulation due to chronic activation. The exis-
tence of a DN T-cell-regulatory population to control
self-reactivity in humans and mice has been proposed
[65,66], and the expanded DN T-cell population in mice
bearing the homozygous Fas
lpr or FasL
gld mutations has
been found to have regulatory properties [67]. The onto-
geny and functional ability of the IIJ DN T cells are cur-
rently under investigation.
The gene mutations and background alleles that might
cause or modify the arthritis phenotype in the IIJ strain
have yet to be identified. It is unlikely that the pheno-
type is related to either the 5B6 TCR transgenes or the
Thy1.1 allele that were present in the line from which
the IIJ strain was derived. A low percentage of periph-
eral blood T cells in the IIJ mice expressed Vb6, the
variable region used in the 5B6-transgenic TCRb chain,
and none of the IIJ mice (> 1,000 animals) have shown
clinical or histological signs of EAE (for example, loss of
muscle tonicity, hindlimb paralysis or inflammation in
the central nervous system). Also, the arthritis occurs
regardless of Thy1 status, as we have identified AR and
NAR IIJ mice that are Thy1.1
+Thy1.2
-,T h y 1 . 1
-Thy1.2
+
and Thy1.1
+Thy1.2
+ (data not shown). Both SJL/J and
FVB background alleles likely contribute to arthritis
development. The strain from which the IIJ mice were
derived was predominantly SJL/J in background. Statisti-
cally, however, with a minimum of only six generations
of backcrossing to SJL/J after generating the 5B6-trans-
g e n i cm i c eo nt h eF V Bb a c k g r o u n d ,as m a l lp e r c e n t a g e
of FVB alleles must be present in the IIJ strain. The fact
that multiple attempts to backcross the AR IIJ mice
further to SJL/J only decreased arthritis incidence also
argues in favor of FVB-influencing alleles. Since back-
crossing AR IIJ mice to FVB inbred mice also resulted
in low AR incidence, SJL/J alleles must also be
important.
T h ep e d i g r e ed o e si n d i c a t et h a tt h ea r t h r i t i sp h e n o -
type is a complex, non-Mendelian trait and, together
with the female bias in incidence, is clearly sex-influ-
enced. The incidence of 32% in the F1 generation after
crossing the “founder” AR male with the SJL/J females
argues for a dominant phenotype (Figure 2). Neverthe-
less, the fact that crossing two NAR IIJ mice yielded a
similar incidence of arthritis suggests that the trait is
also incompletely penetrant, since the NAR parents
must harbor the disease-promoting alleles but do not
display the trait. While it is also possible that a combi-
nation of multiple alleles must be inherited to develop
the disease, the relative consistency of incidence regard-
less of the phenotype of the parents argues against sim-
ple segregation of multiple alleles. Furthermore, at the
time of the writing of this article, the IIJ mice had been
intercrossed for 14 generations and the overall incidence
had not increased, despite the fact that most loci should
be fixed after that much inbreeding. Therefore, while
genes are undoubtedly influencing the phenotype, other
factors, such as microbial stimulation of the innate
immune system, or even stochastic events, such as the
formation of the T- and B-cell repertoires through ran-
dom rearrangements in the TCR and Ig genes, might
also be involved.
Some bacteria, such as Borrelia burgdorferi and Sta-
phylococcus aureus, or microbial products such as zymo-
san, a crude fungal extract of b-glycans, can induce
arthritis in susceptible mouse strains [25-27]. While it
cannot be completely ruled out, there is little evidence
that the arthritis in the IIJ mice is caused purely by an
infectious agent. The mice are maintained in a barrier
facility, and arthritis incidence does not cluster by cage.
Also, SJL/J mice housed in the same cage as AR IIJ
mice never develop arthritis, and SJL/J sentinel mice
that receive portions of bedding from over 20 cages of
IIJ mice housed on the same rack also never develop
arthritis. The IIJ breeding colony was transported
between institutions (from Northwestern University to
Westmont College) in the F3 and F4 generation, but
arthritis incidence did not significantly change after the
move. No viral, bacterial or parasitic pathogen has been
consistently found in the IIJ strain, aside from the mice
with H. rodentium infection, and the AR IIJ mice that
have been treated with antibiotics to clear the Helico-
bacter sp. have remained AR. Nevertheless, even sponta-
neous arthritis can be highly influenced by microbial
flora. For example, the SKG strain has a high incidence
of arthritis in conventional caging conditions and a very
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are injected with zymosan [68]. It is not known whether
a similar innate immune system would trigger an
increased incidence of arthritis in the IIJ mice.
While H. rodentium does not appear to cause the
arthritis phenotype, it seems likely that it is responsible
for or at least contributes to typhlocolitis, since H.
rodentium infection is prevalent in both AR and NAR
IIJ mice and treatment with antibiotics cleared the Heli-
cobacter sp. and resolved the diarrhea and gut inflam-
mation (Figure 9). As mentioned previously, H.
rodentium was identified only 13 years ago, when it was
isolated from asymptomatic laboratory mice [44]. Few
studies have since investigated its pathogenicity. In
experimental monoinfections, H. rodentium did not
cause cecal lesions or significantly change gut gene
expression in either immunocompetent A/JCr mice or
SCID (severe combined immunodeficiency) mice, while,
in parallel experiments, a related species (H. hepaticus)
did [46]. Several studies have found that H. rodentium
exacerbates gastrointestinal inflammation when coin-
fected with other Helicobacter spp. [45-47], although no
other Helicobacter spp. were found in the IIJ mice. If
this bacterial species alone is responsible for the typhlo-
colitis, it might reflect a particular predisposition to
proinflammatory immune responses in IIJ mice. RA as
well as IBDs such as ulcerative colitis and Crohn’sd i s -
ease are chronic inflammatory diseases, and genome-
wide association studies have identified genetic loci that
increase the risk for both [69-72]. Although several case
studies have been published about RA patients who
developed IBD [73,74], IBD is not considered a typical
extraarticular manifestation of RA [2,3]. In contrast,
joint inflammation occurs in 20% of patients diagnosed
with IBD, though it is classified as peripheral or axial
spondyloarthritis [42,43] and is typically seronegative for
RF and anticyclic citrullinated peptide antibodies [75,76].
Conclusion
Overall, the data presented identify the IIJ strain as a
new murine model of inflammatory, possibly autoim-
mune, arthritis. The IIJ strain is similar, both histologi-
cally and serologically, to RA and other murine models
of autoimmune arthritis. In addition, the increased
incidence of arthritis in female IIJ mice makes it a
potentially important model for the study of the
underlying causes of the sex bias in autoimmunity.
Nevertheless, notable differences do exist between the
disease in IIJ mice and human RA. For example, joint
swelling in RA is typically symmetric in humans [1,77],
while it is asymmetric in many of the IIJ mice (Figure
3). Also, the accumulation of DN T cells in the periph-
ery, which is so marked in IIJ mice (Figure 8), is a hall-
mark of SLE, not RA [58]. Despite these differences,
the IIJ strain is a new experimental tool with which to
investigate the genetic and immunological mechanisms
of arthritis.
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